ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)

Detalles Bibliográficos
Autores principales: LANDA, ELISE, FARRA, WASEEM, EHTESHAM, MUHAMMAD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Critical Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503486/
http://dx.doi.org/10.1016/j.chest.2021.07.641
_version_ 1784581132533104640
author LANDA, ELISE
FARRA, WASEEM
EHTESHAM, MUHAMMAD
author_facet LANDA, ELISE
FARRA, WASEEM
EHTESHAM, MUHAMMAD
author_sort LANDA, ELISE
collection PubMed
description
format Online
Article
Text
id pubmed-8503486
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85034862021-10-12 ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) LANDA, ELISE FARRA, WASEEM EHTESHAM, MUHAMMAD Chest Critical Care American College of Chest Physicians. Published by Elsevier Inc. 2021-10 2021-10-11 /pmc/articles/PMC8503486/ http://dx.doi.org/10.1016/j.chest.2021.07.641 Text en Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Critical Care
LANDA, ELISE
FARRA, WASEEM
EHTESHAM, MUHAMMAD
ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
title ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
title_full ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
title_fullStr ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
title_full_unstemmed ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
title_short ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
title_sort endobronchial tissue plasminogen activator (tpa) administration to resolve endobronchial obstruction due to significant blood clot burden in a sar cov 2 positive patient on extracorporeal membrane oxygenation (ecmo)
topic Critical Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503486/
http://dx.doi.org/10.1016/j.chest.2021.07.641
work_keys_str_mv AT landaelise endobronchialtissueplasminogenactivatortpaadministrationtoresolveendobronchialobstructionduetosignificantbloodclotburdeninasarcov2positivepatientonextracorporealmembraneoxygenationecmo
AT farrawaseem endobronchialtissueplasminogenactivatortpaadministrationtoresolveendobronchialobstructionduetosignificantbloodclotburdeninasarcov2positivepatientonextracorporealmembraneoxygenationecmo
AT ehteshammuhammad endobronchialtissueplasminogenactivatortpaadministrationtoresolveendobronchialobstructionduetosignificantbloodclotburdeninasarcov2positivepatientonextracorporealmembraneoxygenationecmo

Ejemplares similares